WAT Waters Corporation Загрузка...

Загрузка графика...
Лучшие сигналы
Лента
Загрузка...
Загрузка...
Загрузка...
Загрузка...
Загрузка...
Загрузка...
0 выбрано
Весь контент✓
Ленты источников
Buzzberg Топ 50 ✓
Все капитализацииБез фильтра по капитализации✓
200 млрд и вышеМега✓
от 10 до 200 млрдКрупные✓
от 2 до 10 млрдСредние✓
от 0 до 2 млрдМалые✓
Свой
Введите диапазон капитализации в млрд USD
Все направления✓
▲ Лонг✓
▼ Шорт✓
⛔ Избегать✓
✂ Закрытие✓
◦ Другие✓
Любая оценка✓
Низкая+✓
Средняя+✓
Высокая✓
? ?
13:00
05 авг ◎
Birgit Girshick CEO, Charles River Laboratories International, Inc. CRL Q2 FY26 call
DSA bookings and book-to-bill hit their highest level in nearly four years (Q3 2022), signalling the start of an industry-wide recovery in preclinical demand, earlier than many expected. — Strong DSA demand may indicate a broader CRO recovery trend; competitors may also see improvements later in 2026.
WAT
Сред.
12:00
04 авг ◎
Amol Chaubal WAT Q2 FY26 call
Management raised every component of FY guidance, citing strong momentum across the portfolio and broad-based end-market recovery, indicating a bullish outlook for the remainder of the year.
WAT
Выс.
13:00
28 июл ◎
Matthew Pine CEO, Xylem Inc. XYL Q2 FY26 call
Although Evoqua is now part of Xylem, its integration is directly credited for enabling Xylem's growth and margin expansion in industrial markets.
WAT
Выс.
12:00
07 мая ◎
Tom Poland Chairman, CEO and President, Becton, Dickinson and Company BDX Q2 FY26 call
The completed combination with Waters' life sciences business is a structural change for BD, but this mention focuses on the execution being ahead of schedule, not on Waters' own outlook.
WAT
Выс.
23:54
05 мая
Jim Cramer Ведущий, Mad Money CNBC
Waters Corp strong life science play
Waters Corporation had an excellent quarter, driven by regulated pharma applications, GLP-1 manufacturing, and strong China pharma growth, making it the best S&P performer today.
WAT 1-й
Выс.
13:17
05 мая
TheLAPurchaser Трейдер акций L/S
TheLAPurchaser highlights Udit's positive influence on Waters Corporation.
TheLAPurchaser highlights Udit's positive influence on Waters Corporation, suggesting renewed momentum in the life sciences sector.
WAT
Выс.
14:02
17 мар
TheLAPurchaser Трейдер акций L/S
The author suggests that the life sciences sector has reached a market floor.
WAT 1-й
21:30
25 фев ◎
Parikh McDonald CEO, Agilent Technologies, Inc. A Q1 FY26 call
Agilent's LC instrument replacement cycle is showing 2x peer growth, driven by the Infinity Tree system, signaling a clear share gain over Waters and Thermo Fisher in high-performance liquid chromatography. — A sustained 2x growth differential in a major instrument category would directly pressure Waters' core business and indicate a structural shift in the competitive landscape.
WAT
Выс.
13:19
17 фев
tacticzh
Terry Smith's top holding is Waters Corp; fund portfolio disclosure.
WAT
Сред.
13:30
09 фев ◎
Dr. Udit Bhatia WAT Q4 FY25 call
Management guides to strong industry-leading 5.3% growth for the combined company, with multiple embedded conservative assumptions (e.g., excluding pricing improvements, reshoring, and China stimulus) leaving room for upside.
WAT
Выс.
13:00
09 фев ◎
Tom Pollin Chairman, Chief Executive Officer and President, Becton, Di… BDX Q1 FY26 call
BD is closing the spin-merger of its life sciences business with Waters, which will create a new combined entity and provide BD with a $4B cash distribution.
WAT
Выс.

Об аналитическом покрытии WAT

Buzzberg отслеживает WAT (Waters Corporation) в 4 источниках. Бычьих сигналов: 2, медвежьих: 0, от 10 аналитиков. Сентимент преимущественно бычий (18%). Всего отслеживается 11 торговых идей. Последние спикеры: Birgit Girshick, Amol Chaubal, Matthew Pine.